Supplementary Figure 4:
NUSAP1 overexpression eventually increases tumor volume while NUSAP1 knockdown decreases tumor volume. PC-3-luc2 cells overexpressing or underexpressing NUSAP1 or controls were subcutaneously injected into the flanks of male SCID-beige mice. A. Caliper measurements of tumor volume over time in mice with tumors overexpressing NUSAP1 versus EGFP. Points: mean ± SEM. EGFP: n = 21; NUSAP: n = 21. B. RNA was harvested from tumors overexpressing NUSAP1 or EGFP at day 50 and RT-qPCR was performed using SYBR green chemistry. Relative NUSAP1 expression was determined by normalization to the universal GAPDH reference gene. Bars: mean ± SD. EGFP: n = 12; NUSAP1: n = 11. C. Caliper measurements of tumor volume over time in mice with tumors underexpressing NUSAP1 versus control. Points: mean ± SEM. Scramble shRNA: n = 10; NUSAP1 shRNA #1: n = 11; NUSAP1 shRNA #2: n = 7. D. RNA was harvested from tumors with knockdown of NUSAP1 or control at day 62 and RT-qPCR was performed using SYBR green chemistry. Relative NUSAP1 expression was determined by normalization to the universal GAPDH reference gene. Bars: mean ± SD. Scramble shRNA: n = 12; NUSAP1 shRNA # 1: n = 9; NUSAP1 shRNA #2: n = 9. All P-values were calculated using the two-tailed Student's t-test. , livers, and spleens) were extracted to quantify metastases by RT-qPCR using SYBR green chemistry. Expression of human-specific GAPDH relative to universal GAPDH was used to quantify metastases, and percentage of mice with metastases was determined for A. all six tissue sites combined and the B. lung, C. right axillary lymph node, D. left axillary lymph node, E. right femoral bone marrow, F. liver, and G. spleen. 
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